Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin.
Indomethacin reversibly inhibited growth of rat hepatoma cells (HTC) and human diploid fibroblasts in the G1 phase of the cell cycle. Cytophotometric measurements showed that greater than 90% of cells incubated for 48 hr with indomethacin had a DNA content that corresponded to the G1 state. Synchronous growth of both the HTC and fibroblast cultures occurred after removal of drug as indicated by the sequence of changes in [3H]thymidine incorporation into DNA, cellular DNA content, mitotic index and cell number. Autoradiographs of HTC cell cultures incubated with [3H]thymidine indicated that all (98%) of the cells engaged in DNA synthesis following the removal of indomethacin. Since viability of the cells was not impaired, even by prolonged exposure to indomethacin, this drug provides a means of synchronizing growth. Suppression of cell proliferation could contribute to the therapeutic and/or toxic effects of indomethacin in vivo.
D000818:Animals; D001345:Autoradiography; D002453:Cell Cycle / Q000187:drug effects*; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D007399:Interphase / Q000187:drug effects*; D007700:Kinetics; D008114:Liver Neoplasms, Experimental / Q000473:pathology; D008940:Mitotic Index / Q000187:drug effects; D051381:Rats; D013997:Time Factors
D004247:DNA; D007213:Indomethacin